srl: Court asks companies to avoid any action that may harm brand SRL

[ad_1]

The Delhi High has asked SRL Diagnostics, SRL and Fortis Healthcare not to take “any action” that diminishes the value of brand SRL.

Earlier, Ranbaxy’s former promoter Shivinder Mohan Singh had approached the court asking it to intervene and pass an order to restrain them from “abruptly duping” and “discontinuing” the trade marks. SRL had last week announced rebranding SRL Diagnostics as Agilus Diagnostics. Japanese pharma major Daiichi Sankyo backed Singh’s plea.

The matter will be taken up in the court again on Thursday for final argument.

On May 23, Singh had approached the court urging to pass an order restraining SRL diagnostics, SRL and Fortis Healthcare. He also asked the court to restrain them from acting in any manner which is detrimental to the value of SRL and allied trade marks.

In his application, Singh further urged the court for an appointment of an independent entity to facilitate the valuation and sale of the SRL and allied trade marks under the supervision of the court. SRL Diagnostics and SRL are the subsidiaries of Fortis Healthcare.

Singh also said that they have been enjoying the SRL and allied trade marks without the payment of requisite brand licence fee/damages for last several years and have “unjustly” enriched themselves, taking unfair advantage of present litigation between them and Daiichi Sankyo.

[ad_2]

Source link


Leave a Reply

Your email address will not be published. Required fields are marked *